Cardiovascular disease has become a great threat to the health of mankind; current titanium (Ti) stents fail due to late stent thrombosis caused by the lack of re-endothelialization of the Ti stent. The objective of this study was to design a novel cardiovascular Ti implant with improved surface biocompatibility. TiO 2 nanotubes with a diameter of 110 nm were anodized at a constant voltage of 30 V, and fibronectin was immobilized onto the TiO 2 nanotubes using polydopamine. The element composition, morphology, and wettability of the different substrate surfaces were characterized by x-ray photoelectron spectroscopy (XPS), field-emission scanning electron microscopy (FE-SEM), atomic force microscopy (AFM), and contact angle measurements, respectively, confirming the successful immobilization of fibronectin. In vitro experiments including immunofluorescence staining, Cell Counting Kit-8 (CCK-8), and nitric oxide (NO) and prostacyclin (PGI2) release demonstrate that fibronectin modified TiO 2 nanotubes supported cell adhesion, proliferation, and normal cellular functions of human umbilical vein endothelial cells (HUVECs). These methodologies can be applied for future fabrication of cardiovascular stents.
Introduction
With cardiovascular disease indiscriminately attacking human's health, a need for cardiovascular related research and medical device advancement is on the rise. 1 Currently, titanium (Ti) and its alloy have been widely used for cardiovascular implants, such as artificial cardiac valve, vascular stent, and coronary stent due to their mechanical and physiochemical properties. 2 However, Ti implant failure due to late stent thrombosis caused by the lack of re-endothelialization of titanium implant still remains a problem. 3 Therefore, it is important to research that focuses on strengthening the interaction between endothelial cells (ECs) and titanium surface be conducted.
We have previously established that TiO 2 nanotubes with varying diameters can be successfully fabricated on titanium surfaces through anodization by adjusting the fabrication parameters. 4 These TiO 2 nanotubes have been found to influence the cellular mobility and differentiation of ECs. 5, 6 The genes and pathways associated with the cellular response to TiO 2 nanotubes were evaluated. 7 Additionally, the special tubular structure and biocompatibility property of TiO 2 nanotubes have made them widely used as a drug delivery system for loading biomolecules and inorganic elements, 8 such as bone morphogenetic protein 2 (BMP2), 4 pamidronic acids, 9 and strontium. 10 In order to encourage cellular adhesion of ECs onto the surface of TiO 2 nanotubes, we chose to modify fibronectin (Fn) onto our constructs. Fn is a high molecular weight glycoprotein in extracellular matrix that plays an important role in regulating cell behavior such as adhesion, spreading, migration, proliferation, and differentiation. [11] [12] [13] It has garnered much attention as a bioactive molecule for modifying biomaterials in the biomedical field. Middleton et al. 14 found that a bioinductive and durable coating of Fn silanized titanium alloys can improve fibroblast attachment in vitro. Research conducted by Yang et al. 15 revealed that Fn modified poly L-lactic acid fiber mats enhance the adhesion, proliferation, and cellular activity of ECs. However, to the best of our knowledge, no one has yet to report using Fn immobilized onto the surfaces of TiO 2 nanotubes for enhancing re-endothelialization of titanium implants. To modify Fn onto TiO 2 nanotubes, polydopamine (PDOP) was employed as an intermediate layer, which has been deemed as a multifunctional biopolymer formed by autopolymerization of dopamine. 16 As it is a direct and effective method, PDOP has been widely used to immobilize bioactive molecules onto surfaces through nucleophiles. 17 Here, TiO 2 nanotubes were fabricated through anodization, and Fn was then grafted onto the surfaces of TiO 2 nanotubes through the PDOP intermediate layer. The goal of this study was to evaluate the biocompatibility of ECs with the Fn modified TiO 2 nanotubes to determine if this fabrication method could aid in the re-endothelialization of vascular stents in clinical applications.
Materials and methods

Materials
Titanium foils (0.25 mm thickness, 99.5%) were provided by Alfa Aesar Co. (Tianjin, China). Fn was purchased from Corning. Rhodamine phalloidin was purchased from Santa Cruz Biotechnology Co. (USA). 4 0 ,6-Diamidino-2-phenylindole dihydrochloride (DAPI), Cell Counting Kit-8 (CCK8), Bicinchoninic Acid (BCA), and nitric oxide (NO) assay kit were supplied by Beyotime Biotechnology Co., Jiangsu, China. Prostacyclin (PGI2) ELISA kit was purchased from Elabscience, Wuhan, China.
Sample fabrication
The fabrication of TiO 2 nanotubes (TNTs) was performed according to a previous literature. 4 Briefly, titanium foil was used as an anode, and platinum as a cathode. It was conducted in electrolytic solution composed of 0.27 M ammonium fluoride in water/glycerol (1:1 v/v) solution at a constant DC potential of 30 V for 1 h. The samples were then ultrasonically cleaned with ethanol for 2 min and distilled water for 10 min, and heated at 400 C for 2 h. Subsequently, the samples were placed in 2 mg/mL dopamine solution overnight under the dark condition. 18 The PDOP formed onto TiO 2 nanotube surfaces, these samples are referred to as TNT-PDOP substrates. The treated samples were further immersed in 0.1 mg/mL Fn solution overnight under dark condition and the treated samples are referred to as TNT-PDOP-Fn substrates.
Sample characterizations
Surface element composition of the substrates was obtained by x-ray photoelectron spectroscopy (XPS) using a Perkin-Elmer model PHI, 5600 XPS system with an Mg Kr source (1253.6 eV). Field-emission scanning electron microscopy (FE-SFM; SUPRATM 55, Zeiss, Germany) and atomic force microscopy (AFM; Dimension Edge, Bruker, Germany) were used to characterize the morphology and roughness of the substrates. Water contact angles were evaluated using a video-based optical system (Model 200, Future Scientific, Taiwan, China).
Cell culture
Frozen human umbilical vein endothelial cells (HUVECs) were thawed and seeded onto culture dishes containing RPMI1640 medium supplemented with 10% (v/v) fetal bovine serum (FBS, Gibco) and 1% (v/v) penicillin/streptomycin (Gibco) at 37 C and containing 5% CO 2 . Once cells reached confluency, they were used for the following experiments.
Immunofluorescence staining
HUVECs were cultured onto Ti, TNT, TNT-PDOP, and TNT-PDOP-Fn substrates at an initial seeding density of 5 Â 10 3 cells/cm 2 and were grown for one or three days, respectively. Cells were washed thrice with phosphate-buffered saline (PBS) and fixed with 2% glutaraldehyde at 4 C for 20 min. Following incubation, cells were washed three more times, and permeabilized using 0.2% Triton X-100 at 4 C for 2 min. The treated samples were then washed with PBS another three times and stained with 5 U/mL rhodaminephalloidin at 4 C overnight and counterstained with 10 lg/mL DAPI at room temperature for 5 min. The stained samples were visualized by fluorescent inverted microscope (Olympus IX71S8F-3, Japan).
Cell Counting Kit-8
HUVECs were cultured onto Ti, TNT, TNT-PDOP, and TNT-PDOP-Fn substrates at an initial seeding density of 5 Â 10 3 cells/cm 2 and cultured for one or three days, respectively. Cells were harvested, washed with PBS, then incubated with 200 lL media containing 20 lL CCK-8 per well at 37 C for 2 h. Finally, the solution was transferred to a 96-well plate and was measured at 450 nm using the microplate reader (BioTek Synergy H4 Hybrid, USA).
NO assay
HUVECs were cultured on different substrates at an initial seeding density of 5 Â 10 3 cells/cm 2 for one or three days, respectively. Then, the supernatant was harvested and centrifuged at 1500g for 15 min to remove cellular debris. NO production of cells was evaluated using a standard griess reagent reaction. The absorbance of solution was measured at 540 nm using a spectrophotometric microplate reader. The NO activity was expressed as lmol/mL.
PGI2 assay
The PGI2 assay was conducted following a previously established protocol. 19 Briefly, cells were cultured on different substrates at an initial density of 5 Â 10 3 cells/cm 2 for one or three days, respectively. At days 0 and 2, 0.5 mL fresh culture medium was added and cells were cultured for an additional one day. The conditioned medium was collected and centrifuged at 1000g for 20 min to remove cell debris and evaluated using an enzyme-linked immunosorbent assay (ELISA). The absorbance of solution was measured at 450 nm using a spectrophotometric microplate reader. The PGI2 concentration (expressed as pg/mL) was determined using a standard absorbance curve corresponding to known concentration of PGI2.
Results
Surface characterization
XPS analysis, shown in Figure 1 , displays the survey scan spectra of pristine and treated TiO 2 nanotubes with their corresponding elemental composition. The pristine TiO 2 nanotube substrate displayed the existence of O, Ti and C (Figure 1(a) ). An additional peak of N at 400.10 eV was observed on the surface of TNT-PDOP substrate (Figure 1(b) ). After immobilized with Fn, N content of TNT-PDOP-Fn substrate surface increased (Figure 1(c)) .
The morphology of different substrate surfaces was observed by field-emission scanning electron microscopy (FE-SEM). As shown in Figure 2 , untreated titanium surface resulted in a relatively smooth surface (Figure 2(a) ). A layer of TiO 2 nanotubes (110 nm in diameter) was formed on the titanium surfaces after anodization at a potential of 30 V (Figure 2(b) ). However, the nanotube structures were partially covered on TNT-PDOP substrate surfaces (Figure 2(c) ). Furthermore, modifying the surface with dopamine and Fn caused a slight changed on the surface morphology compared to PDOP coated TiO 2 nanotubes (Figure 2(c), (d) ). The surface roughness of different substrates was further investigated using AFM. Figure 3 displays the morphology change of Ti, TNT, TNT-PDOP, and TNT-PDOP-Fn surfaces after each treatment step, the corresponding surface average roughness (Rq) over an area at 2 lm Â 2 lm were 17.8 AE 2.0 nm, 34.5 AE 3.0 nm, 42.0 AE 3.4 nm, and 48.7 AE 2.3 nm, respectively.
The water contact angles of TNT, TNT-PDOP, and TNT-PDOP-Fn were measured. The pristine TiO 2 nanotubes displayed the super-hydrophilicity with a low contact angle value of 13.1 AE 3. 4 . Moreover, after modifying the surface with dopamine, the surface water contact angle increased to 40.7 AE 2. 4 . After treatment with Fn, the modified TiO 2 nanotubes demonstrated a decrease with a water contact angle of 34.7 AE 2.7 .
Cell morphology
To better understand the effect of Fn modified TiO 2 nanotubes on cell morphology, actin (cytoskeleton) and the nucleus of HUVECs were observed by immunofluorescence staining technique. Figure 4 depicts fluorescent images of HUVECs on the different substrates after one and three days of culture. The cell number and the spreading area of cells on all substrate surfaces were increased with increasing time in the culture. The cell morphology on TNT surfaces was elongated and displayed a decreased cell number for each respective time point when compared to cells on Ti surfaces. Furthermore, the amount and spreading area of HUVECs on TNT-PDOP-Fn substrate surface were higher than those on other groups.
Cell proliferation
To examine proliferation of HUVECs on the pristine and modified TiO 2 nanotubes, CCK-8 assay was employed in this study. Figure 5 shows the viability of HUVECs grown on Ti, TNT, TNT-PDOP, and TNT-PDOP-Fn substrates after one and three days of culture. As compared to Ti substrate, cells grown onto TNT substrate showed lower (p < 0.05) cell viability after one and three days of culture. Furthermore, cells cultured on TNT-PDOP-Fn substrates exhibited significantly higher (p < 0.01 or p < 0.05) cell viability compared to other groups.
Cell function
To further evaluate the function of HUVECs grown on the surfaces of different substrates, NO and PGI2 production were measured, respectively. The NO content secreted by HUVECs grown on different substrates is shown in Figure 6 . Compared to Ti group, there is a significant increase (p < 0.01 or p < 0.05) in NO production of HUVECs grown on TNT substrates after one and three days of culture. Furthermore, the HUVECs cultured on TNT-PDOP-Fn substrates showed the highest (p < 0.01 or p < 0.05) NO secretion among all groups both after one and three days of culture. Figure 7 shows the PGI2 level produced by HUVECs grown on different substrates. Cells cultured on TNT substrates displayed significantly higher (p < 0.01 or p < 0.05) PGI2 production than those of Ti substrates after one and three days of culture. Moreover, Fn functionalized TiO 2 nanotubes showed highest (p < 0.01 or p < 0.05) PGI2 production among all groups after one and three days of culture, respectively.
Discussion
TiO 2 nanotubes are commonly employed as a drug delivery system in biomedical application for their special nanotubular structure, 20 it has also been well established that TiO 2 nanotubes can enhance the function of ECs. 5 In addition, Fn, an extracellular matrix protein, has been used to modify biomaterial surfaces for improving the biocompatibility with ECs. 21, 22 In this study, to construct a proper extracellular microenvironment of chemical and topographical properties, we presented a practical method to immobilize Fn onto the TiO 2 nanotubes through an intermediate layer of PDOP for endothelialization.
The XPS results showed how the surface chemical composition changed after each grafting step. The different surface morphology and substrate roughness were observed using the SEM and AFM. In addition, as the chemical modification, the water contact angle was also changed. Taken together, these results demonstrate that Fn was successfully immobilized onto the surface of TiO 2 nanotubes.
Since rapid re-endothelialization plays a key role in the success of a cardiovascular implant device, it is important to assess the interaction between ECs and Fn modified TiO 2 nanotubes. Initially, cell adhesion and spreading are the first events upon implantation of the stent, this in turn regulates cell proliferation and function. 23, 24 Figures of immunofluorescence staining indicated that the addition of Fn played a vital role in cell adhesion and spreading. As Fn modified TiO 2 nanotube substrate promoted the adhesion and spreading of HUVECs, thereby regulating downstream proliferation and functionality of HUVECs. CCK-8 assay results indicated that the TiO 2 nanotubes with a larger diameter had an adverse effect on the cytocompatibility. 5, 25 And Fn modified TiO 2 nanotubes promoted the proliferation of HUVECs, as Fn is a naturally occurring glycoprotein in the extracellular matrix and is not cytotoxic. 26 The increase in proliferation of HUVECs on the TNT-PDOP-Fn substrates reinforced the increased functionality on Fn modified TiO 2 nanotubes. NO is continuously secreted by ECs and plays a critical role in maintaining vessel homeostasis by inhibiting platelet aggregation, preventing blood coagulation, and promoting angiogenesis, 27 while PGI2 is secreted by ECs and has anti-thrombogenicity and anti-proliferation properties on vascular smooth muscle cells. 28 HUVECS on TNT-PDOP-Fn substrates had an increased nitric NO and PGI2 production, further corroborating the increased functionality of HUVECs on Fn modified TiO 2 nanotubes.
It has been well established that the cell behaviors are regulated by extracellular microenvironment properties. 29 The various surface topography sizes including the mesoscale, microscale, and nanoscale are one of the most important factors modulating cell adhesion, proliferation, and differentiation. [30] [31] [32] [33] Here the behavior of ECs was influenced by the surface topography of TiO 2 nanotubes at the nanometer scale. In addition, chemical properties of the different substrate surfaces also play a vital role in regulating cellular response. 34, 35 Fn, a glycoprotein of the extracellular matrix, positively contributed to the maintenance of normal ECs behaviors, which has been shown to signal through the a5b1 transmembrane integrin receptors. 36, 37 Therefore, these results indicated that Fn and the nanostructure of TiO 2 nanotubes could synergistically enhance the function of ECs.
Conclusions
In conclusion, Fn modified TiO 2 nanotubes were successfully fabricated through PDOP as an intermediate layer, which was confirmed by XPS, SEM, AFM, and contact angle measurement, respectively. The behavior of HUVECs including cell morphology, cell viability, and the production of NO and PGI2 were enhanced by Fn functionalized TiO 2 nanotubes. Further studies need to be conducted in vivo. In this study, the surface biofunctionalization of TiO 2 nanotubes described here lays the groundwork for cardiovascular based titanium implants for rapid re-endothelialization.
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